LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive Account

Home News ArchiveHansoh Pharma Says Risvutatug Rezetecan Improves Progression-Free Survival in Phase 3 Osteosarcoma Study

Live News EQUITY FLASH M impact Oct 26, 2026, 11:49 PM UTC

Hansoh Pharma Says Risvutatug Rezetecan Improves Progression-Free Survival in Phase 3 Osteosarcoma Study

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Nasdaq futures rise 0.24%, S&P futures gain 0.17% At 11:00, Nasdaq futures were up 0.24% and S&P futures were up 0.17%. M impact | EQUITY | Oct 27, 2026, 02:00 AM UTC Legend Holdings Reports Q3 Net Profit Attributable of RMB100.5 Million M impact | EQUITY | Oct 27, 2026, 01:59 AM UTC China STAR 50 index falls 40% from July peak The index’s decline may weigh on technology-sector financing and IPO plans, Reuters reports; valuations remain high relative to the US. M impact | EQUITY | Oct 27, 2026, 01:58 AM UTC Wanhua Chemical rises 4.1% as Q3 net profit grows Wanhua Chemical shares rose 4.1% in Tuesday morning trading, reaching a two-week high. The company said third-quarter net profit increased. M impact | EQUITY | Oct 27, 2026, 01:56 AM UTC NGX Secures Rights to Acquire Up to 85% in Seven Damara Gold Belt Licences NGX secured rights to acquire up to 85% in seven exploration licences in the Damara Gold Belt. M impact | EQUITY | Oct 27, 2026, 01:56 AM UTC NGX Secures Rights to Acquire Up to 85% in Seven Exploration Licences NGX secured rights to acquire up to 85% in seven exploration licences in the Damara Gold Belt. M impact | EQUITY | Oct 27, 2026, 01:56 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.